Clinical trial
Oral Contraceptive Interaction Study for GW273225
NCT00483535 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00483535 |
|---|---|
| Title | Oral Contraceptive Interaction Study for GW273225 |
| Official title | An Open, Repeat Dose Study to Investigate the Effect of Co-administration of the Combined Oral Contraceptive Pill (COC) and GW273225 on the Pharmacokinetics of the COC and to Investigate the Effects of the COC on the Pharmacokinetics of GW273225 in Healthy Female Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | GW273225, COC |
| Enrollment | 12 |
| Start date | Mar 7, 2007 |
| Primary completion | Nov 16, 2007 |
| Completion | Nov 16, 2007 |
| First posted | Jun 7, 2007 |
| Last update posted | Aug 8, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: